Related Experiment Videos

Identification of two mutations in a compound heterozygous child with dihydrolipoamide dehydrogenase deficiency

Y S Hong1, D S Kerr, W J Craigen

  • 1Department of Biochemistry, School of Medicine and Biomedical Sciences, State University of New York at Buffalo 14214, USA.

Human Molecular Genetics
|December 1, 1996
PubMed

Insights

Dihydrolipoamide dehydrogenase (E3) deficiency in an infant was caused by two novel mutations. These genetic defects, identified through DNA sequencing, led to reduced E3 enzyme activity and protein levels, impacting metabolism.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Dihydrolipoamide dehydrogenase (E3) is a crucial enzyme in the pyruvate dehydrogenase complex, essential for cellular energy metabolism.
  • Deficiency in E3 activity can lead to severe metabolic disturbances, including lactic acidosis and neurological dysfunction.

Related Concept Videos